Overexpression of hypoxia-inducible factor 1α is associated with an unfavorable prognosis in lymph node-positive breast cancer

Clinical Cancer Research

Volumn 8, Issue 6, 2002, Pages 1831-1837

  Schindl, Monika ^a   Schoppmann, Sebastian F ^a   Samonigg, Hellmut ^b   Hausmaninger, Hubert ^c   Kwasny, Werner ^c   Gnant, Michael ^a   Jakesz, Raimund ^a   Kubista, Ernst ^a   Birner, Peter ^a   Oberhuber, Georg ^a   Jakesz, R ^d   Gnant, M ^d   Kubista, E ^d   Seifert, M ^d   Agstner, I ^d   Dadak, C ^d   Dubsky, P ^d   Galid, A ^d   Gebhard, B ^d   Hantal, E ^d   Helbich, H ^d   Joura, E ^d   Kandioler Eckersberger, D ^d   Oberhuber, K ^d   Ploner, M ^d   Reiner, G ^d   Roka, S ^d   Rudas, M ^d   Sam, C ^d   Schemper, M ^d   Schmidinger, M ^d   Steger, G ^d   Steiner, B ^d   Taucher, S ^d   Wenzl, K ^d   Wolf, G ^d   Hausmaninger, H ^e   Mlineritsch, B ^e   Menzel, R C ^e   Hell, E ^e   Kogelnik, H ^e   Moritz, E ^e   Papp, C ^e   Schandalik, R ^e   Umlauft, M ^e   Waclawiczek, H ^e   Samonigg, H ^b   Mischinger, H J ^b   Steindorfer, P ^b   Andritsch, E ^b   Bacher, H ^b   Bauernhofer, T ^b   Berger, A ^b   Cervenka, H ^b   El Shabrawi, A ^b   Freisinger, J ^b   Hauser, H ^b   Hebenstreit, J ^b   Hofmann, G ^b   Kasparek, A K ^b   Konstantiniuk, P ^b   Kosina, G ^b   Krippl, P ^b   Kronberger, L ^b   Kuss, I ^b   Luschin Ebengreuth, G ^b   Moser, R ^b   Papadi, H ^b   Pfeifer, H ^b   Ploner, F ^b   Reinisch, S ^b   Riegler, M ^b   Rosanelli, G ^b   Schippinger, W ^b   Schmid, M ^b   Schwaiger, W ^b   Smola, M ^b   Stoger H ^b   Thalhammer, M ^b   Thiel, I ^b   Wagner, P ^b   Wehrschutz M ^b   Winter, R ^b   Zehetleitner, G ^b   Depisch, D ^f   Kwasny, W ^f   Haider, K ^f   Payrits, T ^f   Kolb, R ^g   Tausch, C ^h   Aufschnaiter, M ^h   Heck, D ^h   Klug, R ^h   Kugler, F ^h   Schildberger, R ^h   Stierer, M ⁱ   Matzinger, H ⁱ   Spoula, H ⁱ   Omann, J ^o   Schiessel, R ^j   Schmidbauer, U ^k   Wunderlich, M ^k   Fridrik, M ^l   Wahl, G ^l   Bauer, D ^m   Hofbauer, F ^m   Lang, M ^m   Jatzko, G ⁿ   Wette, V ⁿ   Starlinger, M ^o   Urbania, A ^o   Keller, K ^p   Schennach, W ^p   Zoller, H ^p   Klug, E ^q   Mach, K ^q   Steflitsch, K ^q   Berger, J ^r   Lenzhofer, R ^r   Winter, G ^r   Haid, A ^s   Koeberle, R ^s   Zimmermann, G ^s   more..

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

^c Landeskrankenhaus Salzburg ^*  (Austria)

^d UNIVERSITY OF VIENNA   (Austria)

^e University Hospital Salzburg   (Austria)

^f Wiener Neustadt Hospital   (Austria)

^g Waehring Lutheran Hospital Vienna   (Austria)

^h BHS Hospital Linz   (Austria)

ⁱ Hanusch Hospital Vienna   (Austria)

^j Hospital SMZ Ost   (Austria)

^k Vienna City Hospital   (Austria)

^l KEPLER UNIVERSITY HOSPITAL   (Austria)

^m Hospital Oberpullendorf   (Austria)

ⁿ BHB Hospital St Veit Glan   (Austria)

^o GENERAL HOSPITAL KLAGENFURT   (Austria)

^p Hospital Zams   (Austria)

^q Oberwart Hospital   (Austria)

^r Schwarzach Hospital   (Austria)

^s Hospital Feldkirch   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECEPTOR DENSITY;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; MICROSCOPY, CONFOCAL; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; SURVIVAL RATE; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036278899     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Oncogenic alterations of metabolism
2. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
3. 2 homeostasis by hypoxia-inducible factor 1
4. 2 tension
5. 2 tension
6. Hypoxia-inducible factor 1α is a positive factor in solid tumor growth
7. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
8. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor associated macrophages
9. HIF-1 and human disease: One highly involved factor
10. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early stage invasive cervical cancer
11. Expression of hypoxia-inducible factor 1α in epithelial ovarian tumors: Its impact on prognosis and on response to chemotherapy
12. Expression of hypoxia-inducible factor 1α in oligodendrogliomas: Its impact on prognosis and on neoangiogenesis
13. Expression of hypoxia-inducible factor-1α: A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer
14. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation, and tumor angiogenesis
15. Stabilization of wild-type p53 by hypoxia-inducible factor 1α
16. Correlation of TP53 mutations and p53 overexpression in ovarian tumors
17. Levels of hypoxia-inducible factor 1α during breast carcinogenesis
18. Identification of p53 mutations by means of single strand confirmation polymorphism analysis in gynaecological tumours: Comparison with the results of immunohistochemistry
19. Die therapiestudien der Austrian Breast Cancer group (ABC)
20. Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer
21. Expression of hypoxia-inducible factor 1α in brain tumors. Association with angiogenesis, invasion, and progression
22. Impact of human papillomavirus infection on the expression of the KAI1 metastasis suppressor protein in invasive cervical cancer
23. Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer
24. Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer
25. Nonparametric estimation from incomplete observations
26. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
27. Breast disease
28. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors
29. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
30. Flavopiridol, a protein kinase inhibitor, down-regulates hypoxic induction of vascular endothelial growth factor expression in human monocytes
31. UCN-01, a protein kinase C inhibitor, inhibits endothelial cell proliferation and angiogenic response
32. Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3′-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
33. Targeting gene expression to hypoxic tumor cells